Filter
542
Text search:
TB
panel
Featured
64
157
Language
Document type
320
87
77
30
17
5
3
1
1
Countries / Regions
49
20
19
13
12
12
9
9
9
7
7
7
7
7
6
6
6
6
6
6
5
5
5
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
197
66
20
20
14
10
8
Toolboxes
134
61
24
23
19
16
15
14
11
11
7
6
5
5
5
3
2
2
2
1
1
1
15. Euro Surveill. 2017;22(47):pii=17-00103
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn
...
This ToR outlines the background, purpose,
audience, and use of the evaluation, objective and key evaluation questions,
methodological considerations, timeline and deliverables, and the technical
requirements the prospective evaluation team should meet
Guidelines for the Prevention and Treatment of Opportunistic Infections in Children With and Exposed to HIV
recommended
Full Guidelines
Dosing Recommendations for Prevention and Treatment
The main objective of this guidance is to provide scientific advice, based on an evidence-based assessment of targeted public health interventions, to facilitate effective screening and vaccination for priority infectious diseases among newly arrived migrant populations to the EU/EEA. It is intended
...
Healthcare Waste Management Toolkit for Global Fund Practitioners and Policy Makers: Part A
CẨM NANG AN TOÀN SINH HỌC PHÒNG XÉT NGHIỆM LAO.
NHÀ XUẤT BẢN Y HỌC HÀ NỘI - 2015.
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordinating Group on Antimicrobial Resistance who release
...
Frontiers in Pediatrics | www.frontiersin.org
1 April 2019 | Volume 7 | Article 159
Over the 20 years that followed, this unique partnership has invested more than US$53 billion, saving 44 million lives and reducing the combined death rate from the three diseases by more than half in the countries in which the Global Fund invests.
